Rheumatoid Arthritis
This study will evaluate the effectiveness of an investigational medication
in controlling symptoms of rheumatoid arthritis, when taken in addition
to methotrexate. Participants must be at least 18, have active rheumatoid
arthritis, be taking 10 mg. to 25 mg. of methotrexate per week, and have
at least six tender joints and at least six swollen joints.
The research site is in Salt Lake City, Utah.
More information
Please see http://www.centerwatch.com/patient/studies/cat132.html.
-----
Copyright ArthritisInsight.com